巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Adaptive Biotechnologies Corp

    ADPT
    8.110
    0.550
    7.28%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Adaptive Biotechnologies Corp - 延遲價格・最後更新於 27/05 4:14
    最高位
    8.150
    最低位
    7.620
    開市價
    --
    前收市價
    7.560
    成交量(千)
    15.22
    成交額(百萬)
    1.03
    買入
    8.110
    賣出
    8.140
    每手股數
    --
    市值(百萬)
    1,153.47
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    43.397 - 6.200
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Adaptive Biotechnologies Corp
    證券代碼
    ADPT.US
    所屬板塊
    Biotechnology
    公司業務
    Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
    發行量
    141583720
    公司總部
    1551 Eastlake Avenue East, Suite 200
    公司網址
    https://www.adaptivebiotech.com
    公司電話
    +1 206 659-0067
    暫無內容

    關於

    Adaptive Biotechnologies Corp(ADPT.US)所屬的行業板塊為Biotechnology。
    Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
    詳細公司背景可參考: https://www.adaptivebiotech.com